ArticleLeukemia research2025

Optimal therapeutic strategies in relapsed/refractory AML with prior exposure to venetoclax-based therapy.

Sawyer Bawek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.